Adcendo Completes Oversubscribed $135 Million Series B Financing
December 03, 2024
December 03, 2024
BOSTON, Massachusetts, Dec. 3 -- Goodwin, a law firm, issued the following news release:
The London Life Sciences team advised Adcendo on the closing of an oversubscribed $135 million Series B financing round.
The financing round was led by TCGX, with participation from new investors TPG Life Sciences Innovations, Orbimed Advisors, Venrock Healthcare Capital Partners, Surveyor Capital (a Citadel company), and Logos Capital, as well as all existing investors, RA Capital . . .
The London Life Sciences team advised Adcendo on the closing of an oversubscribed $135 million Series B financing round.
The financing round was led by TCGX, with participation from new investors TPG Life Sciences Innovations, Orbimed Advisors, Venrock Healthcare Capital Partners, Surveyor Capital (a Citadel company), and Logos Capital, as well as all existing investors, RA Capital . . .